Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of HBV Vaccination on HBsAg Kinetics in Chronic Hepatitis B
NCT03193775Completed
- Sponsor
- Zagazig University
- Start
- Aug 2011
- Primary completion
- Oct 2015
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Open-label trial of hepatitis b vaccine recombinant in hepatitis B (HBV) (2 arms), sponsored by Zagazig University. Primary endpoint: Production of protective HBsAb. Started Aug 2011; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT03193775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03193775.